Written answers

Thursday, 2 February 2017

Department of Health

Medicinal Products Availability

Photo of Shane CassellsShane Cassells (Meath West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

244. To ask the Minister for Health the measures he will put in place to reduce waiting times for multiple sclerosis sufferers who require assessment as responders to fampridine, based on a protocol provided by clinical experts; and if he will make a statement on the matter. [4984/17]

Photo of Shane CassellsShane Cassells (Meath West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

245. To ask the Minister for Health the measures he will put in place to expedite access to fampyra for multiple sclerosis sufferers identified as responders to fampridine; and if he will make a statement on the matter. [4985/17]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 244 and 245 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.